Barely Significant
← all excerpts

Cognitive effects of dopaminergic treatment in Alzheimer's disease: Systematic review and meta-analysis.

Alzheimers Dement (N Y) · 2025 · PMC12365664 · PMID 40842491

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

moderately significantP = 0.01actually significant
When exploring subgroups (divided by mechanism of action), 5 trials of dopamine reuptake inhibitors did not show a significant effect on cognition, whereas 12 monoamine oxidase B (MAO‐B) inhibitor trials showed a moderately significant positive effect (SMD: 0.52, 95% CI: 0.13 to 0.90, P = 0.01; I 2 = 84%).

also in 2,182 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.